Bone morphogenetic protein-4 inhibits proliferation and induces apoptosis of multiple myeloma cells
- 15 January 2001
- journal article
- Published by American Society of Hematology in Blood
- Vol. 97 (2) , 516-522
Abstract
Bone morphogenetic proteins (BMPs) can be isolated from organic bone matrix and are able to initiate de novo cartilage and bone formation. Here it is shown that BMP-4 inhibited DNA synthesis in a dose-dependent manner in 3 IL-6–dependent multiple myeloma (MM) cell lines (OH-2, IH-1, and ANBL-6). In contrast, no effect on DNA synthesis was observed in 3 IL-6–independent MM cell lines (JJN-3, U266, and RPMI 8226). BMP-4 induced cell cycle growth arrest in the G0/G1 phase in OH-2 and ANBL-6 cells but not in IH-1 cells. BMP-4 induced apoptosis in OH-2 and IH-1 cells, but not significantly in ANBL-6 cells. Furthermore, BMP-4 induced apoptosis in freshly isolated MM cells from 4 of 13 patients. In the OH-2 and ANBL-6 cell lines and in a patient sample, immunoblotting showed that BMP-4 down-regulated IL-6–induced tyrosine phosphorylation of Stat3, suggesting a mechanism for the apparent antagonism between IL-6 and BMP-4. BMP-4 or analogues may be attractive therapeutic agents in MM because of possible beneficial effects on both tumor burden and bone disease.Keywords
This publication has 54 references indexed in Scilit:
- Differentiation of Human Marrow Stromal Precursor Cells: Bone Morphogenetic Protein-2 Increases OSF2/CBFA1, Enhances Osteoblast Commitment, and Inhibits Late Adipocyte MaturationJournal of Bone and Mineral Research, 1999
- Should alpha-interferon be included as standard treatment in multiple myeloma?European Journal of Cancer, 1998
- Growth Control Mechanisms in Multiple MyelomaLeukemia & Lymphoma, 1998
- Evidence for the upregulation of osteogenic protein‐1 mRNA expression in musculoskeletal neoplasmsJournal of Orthopaedic Research, 1998
- Expression of Apo‐1/Fas (CD95), Bcl‐2, Bax and Bcl‐x in myeloma cell lines: relationship between responsiveness to anti‐Fas mab and p53 functional statusBritish Journal of Haematology, 1997
- The Plasmacytoma Growth Inhibitor Restrictin-P Is an Antagonist of Interleukin 6 and Interleukin 11Journal of Biological Chemistry, 1995
- Interleukin-6 Inhibits Apoptosis of Malignant Plasma CellsCellular Immunology, 1995
- Activin A Induces Apoptotic Cell DeathBiochemical and Biophysical Research Communications, 1993
- Lack of IL‐1 secretion from human myeloma cells highly purified by immunomagnetic separationBritish Journal of Haematology, 1993
- Recombinant interferon- γ inhibits the growth of IL-6-dependent human multiple myeloma cell lines in vitroEuropean Journal of Haematology, 1991